Clinical Trial Detail

NCT ID NCT04042831
Title Olaparib in Treating Patients With Metastatic Biliary Tract Cancer With Aberrant DNA Repair Gene Mutations
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Academic and Community Cancer Research United
Indications

bile duct adenocarcinoma

Therapies

Olaparib

Age Groups: adult senior

Additional content available in CKB BOOST